Point72 Asia (Singapore)’s X4 Pharmaceuticals XFOR Stock Holding History

Point72 Asia (Singapore)’s Portfolio XFOR Stock Details XFOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$9.97K	Buy	+2,914	New	+$7.51K	﹤0.01%	781

Other funds holding XFOR

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asia (Singapore)'s XFOR Position: Q3 2025 in Review

Point72 Asia (Singapore) opened a new position in X4 Pharmaceuticals (XFOR) in Q3 2025: 2,914 shares worth $9.97K. The stake represents ﹤0.01% of the portfolio and ranks #781 among its holdings.

42 funds tracked by Wall St. Rank hold XFOR as of Q3 2025.

Point72 Asia (Singapore) held 2,914 shares of X4 Pharmaceuticals worth $9.97K as of Q3 2025.
X4 Pharmaceuticals was a new Point72 Asia (Singapore) position in Q3 2025.
X4 Pharmaceuticals made up ﹤0.01% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #781 holding.
42 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.